Clinical Trial Update: Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigated the effects of a double dose of alpha-1 antitrypsin augmentation therapy on lung inflammation in patients with alpha-1 ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Lung Inflammation

Drugs mentioned

• Alpha-1 antitrypsin augmentation therapy (alpha-1 antitrypsin)

Snippet

Sponsor: Michael Campos, MD | Conditions: Alpha 1 Antitrypsin Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08